Share
clock Created with Sketch. 24/10/14
12:29
Share
Originally posted by Homer
↑
The stand-out information for me is about Epichem. It is already truly international and profitable, which is most impressive. The new information is the objective to aim for 1% of the market or US$10m in revenues by 2020 (perhaps A$11-12m?). This compares to A$1.89m in 2014. So somewhere between an A$8m increase in revenue at parity or $10m increase if the A$ is at 80 cents over six years. The bulk of this revenue increase should fall to the bottom line. Not bad at all. And what is important to me is this is not some pipe dream. The business was formed in 2003 and is already more than 10 years old. The creation of this business is a success and a credit to management.
Expand
Perhaps not a ''slam dunk' but a 'no-brainer' at this price (when it was .09) when you consider the company, with epichem might be worth that price alone, or close to it, you basically get a free crack to see if the trials will work out ok and if they do you're staring at a multi bagger. Casinos would go broke with those odds.
(20min delay)